HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-APR-11 3RPS TITLE STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP-COMPETITIVE TITLE 2 INHIBITOR 3-(4,5,6,7-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1-335; COMPND 5 SYNONYM: CK II ALPHA; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS EUKARYOTIC PROTEIN KINASE FOLD, ATP CK2BETA, PHOSPHORYLATION, KEYWDS 2 CYTOPLASM NUCLEUS, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.BISCHOFF,J.RAAF,B.OLSEN,M.BRETNER,O.-G.ISSINGER,K.NIEFIND REVDAT 3 28-FEB-24 3RPS 1 REMARK REVDAT 2 21-AUG-13 3RPS 1 JRNL VERSN REVDAT 1 08-JUN-11 3RPS 0 JRNL AUTH N.BISCHOFF,J.RAAF,B.OLSEN,M.BRETNER,O.G.ISSINGER,K.NIEFIND JRNL TITL ENZYMATIC ACTIVITY WITH AN INCOMPLETE CATALYTIC SPINE - JRNL TITL 2 INSIGHTS FROM A COMPARATIVE STRUCTURAL ANALYSIS OF HUMAN JRNL TITL 3 CK2ALPHA AND ITS PARALOGOUS ISOFORM CK2ALPHA' JRNL REF MOL.CELL.BIOCHEM. V. 356 57 2011 JRNL REFN ISSN 0300-8177 JRNL PMID 21739153 JRNL DOI 10.1007/S11010-011-0948-5 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.BISCHOFF,B.OLSEN,J.RAAF,M.BRETNER,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL STRUCTURE OF THE HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT REMARK 1 TITL 2 CK2 AND INTERACTION THERMODYNAMICS WITH THE REGULATORY REMARK 1 TITL 3 SUBUNIT CK2 REMARK 1 REF J.MOL.BIOL. V. 407 1 2011 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 21241709 REMARK 1 DOI 10.1016/J.JMB.2011.01.020 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.NIEFIND,B.GUERRA,I.ERMAKOWA,O.G.ISSINGER REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2: INSIGHTS INTO REMARK 1 TITL 2 BASIC PROPERTIES OF THE CK2 HOLOENZYME. REMARK 1 REF EMBO J. V. 20 5320 2001 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 11574463 REMARK 1 DOI 10.1093/EMBOJ/20.19.5320 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 29111 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 912 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2053 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.1880 REMARK 3 BIN FREE R VALUE SET COUNT : 69 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5634 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 145 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -21.22000 REMARK 3 B22 (A**2) : -21.22000 REMARK 3 B33 (A**2) : 42.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.051 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.147 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.915 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5810 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4052 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7858 ; 0.921 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9754 ; 2.107 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 666 ; 5.077 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 314 ;33.383 ;23.057 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1028 ;14.426 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 52 ;13.312 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 810 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6406 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1274 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3338 ; 1.197 ; 6.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1336 ; 0.204 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5422 ; 1.764 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2472 ; 2.118 ; 9.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2436 ; 2.751 ; 9.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.501 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : -H, K, -L REMARK 3 TWIN FRACTION : 0.499 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 12 REMARK 3 RESIDUE RANGE : A 117 A 335 REMARK 3 ORIGIN FOR THE GROUP (A): 9.4760 -19.9440 -2.0620 REMARK 3 T TENSOR REMARK 3 T11: 0.2568 T22: 0.3811 REMARK 3 T33: 0.0611 T12: 0.0220 REMARK 3 T13: 0.0039 T23: 0.0064 REMARK 3 L TENSOR REMARK 3 L11: 3.5976 L22: 2.1842 REMARK 3 L33: 3.5442 L12: -0.3284 REMARK 3 L13: 0.0353 L23: -1.5758 REMARK 3 S TENSOR REMARK 3 S11: -0.0564 S12: 0.2067 S13: 0.3958 REMARK 3 S21: -0.1480 S22: 0.0610 S23: 0.1077 REMARK 3 S31: -0.1370 S32: -0.2653 S33: -0.0045 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 13 A 116 REMARK 3 ORIGIN FOR THE GROUP (A): 23.4580 -40.9240 4.7510 REMARK 3 T TENSOR REMARK 3 T11: 0.4744 T22: 0.4920 REMARK 3 T33: 0.0734 T12: 0.0675 REMARK 3 T13: 0.0043 T23: 0.0328 REMARK 3 L TENSOR REMARK 3 L11: 1.6252 L22: 5.7000 REMARK 3 L33: 6.6044 L12: -1.4138 REMARK 3 L13: -2.0727 L23: 4.8397 REMARK 3 S TENSOR REMARK 3 S11: 0.1184 S12: -0.1312 S13: 0.0939 REMARK 3 S21: -0.1648 S22: 0.0809 S23: -0.4568 REMARK 3 S31: 0.5116 S32: 0.4413 S33: -0.1994 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 12 REMARK 3 RESIDUE RANGE : B 117 B 335 REMARK 3 ORIGIN FOR THE GROUP (A): 15.9610 -26.4290 -46.6750 REMARK 3 T TENSOR REMARK 3 T11: 0.3778 T22: 0.2499 REMARK 3 T33: 0.0608 T12: 0.0346 REMARK 3 T13: -0.0062 T23: -0.0062 REMARK 3 L TENSOR REMARK 3 L11: 2.3589 L22: 3.8517 REMARK 3 L33: 4.0270 L12: 0.0376 REMARK 3 L13: 1.4179 L23: -0.3577 REMARK 3 S TENSOR REMARK 3 S11: 0.0359 S12: -0.0943 S13: -0.1393 REMARK 3 S21: 0.2907 S22: -0.0202 S23: -0.4394 REMARK 3 S31: 0.2280 S32: 0.1052 S33: -0.0158 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 13 B 116 REMARK 3 ORIGIN FOR THE GROUP (A): -4.9080 -12.4210 -53.3150 REMARK 3 T TENSOR REMARK 3 T11: 0.5145 T22: 0.4705 REMARK 3 T33: 0.1153 T12: 0.0529 REMARK 3 T13: -0.0339 T23: -0.0122 REMARK 3 L TENSOR REMARK 3 L11: 5.4355 L22: 2.1047 REMARK 3 L33: 5.4438 L12: -2.0963 REMARK 3 L13: -4.0232 L23: 1.5651 REMARK 3 S TENSOR REMARK 3 S11: 0.1824 S12: -0.0608 S13: 0.5437 REMARK 3 S21: -0.0884 S22: 0.0881 S23: 0.0618 REMARK 3 S31: -0.6542 S32: -0.3964 S33: -0.2705 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3RPS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-APR-11. REMARK 100 THE DEPOSITION ID IS D_1000065227. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30062 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 19.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.56000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 99.84000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.28000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 49 -27.11 -36.11 REMARK 500 TYR A 50 32.99 -143.53 REMARK 500 PRO A 72 89.54 -48.63 REMARK 500 VAL A 116 -86.36 -123.99 REMARK 500 GLN A 126 34.01 -91.53 REMARK 500 THR A 127 30.68 -163.06 REMARK 500 ASP A 156 43.85 -149.01 REMARK 500 ASP A 175 84.42 55.31 REMARK 500 ALA A 193 -169.07 77.07 REMARK 500 ASP A 210 -156.01 -157.15 REMARK 500 HIS A 234 74.84 -100.05 REMARK 500 HIS A 286 -71.32 -165.28 REMARK 500 SER A 287 -90.90 -105.16 REMARK 500 GLU A 288 57.46 -99.17 REMARK 500 ASN A 289 0.66 -157.10 REMARK 500 MET A 334 -46.45 -152.54 REMARK 500 ARG B 47 -19.57 76.66 REMARK 500 LYS B 49 -61.37 -94.03 REMARK 500 PRO B 72 114.99 -29.88 REMARK 500 LYS B 74 118.62 -39.27 REMARK 500 ASP B 103 133.10 -37.84 REMARK 500 GLN B 123 48.35 -95.81 REMARK 500 LEU B 124 -44.50 -174.61 REMARK 500 TYR B 125 4.82 -62.86 REMARK 500 ASP B 156 43.73 -157.08 REMARK 500 ASP B 175 61.84 65.32 REMARK 500 ALA B 193 158.07 63.76 REMARK 500 MET B 208 49.26 -89.28 REMARK 500 TYR B 211 -37.51 -38.94 REMARK 500 ARG B 228 72.86 51.90 REMARK 500 LYS B 229 91.76 -164.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4B0 A 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 339 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 338 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OFM RELATED DB: PDB REMARK 900 THE PARALOGOUS ISOENZYM CK2ALPHA' WITH THE SAME INHIBITOR LIGAND REMARK 900 RELATED ID: 1JWH RELATED DB: PDB REMARK 900 THE HETEROTETRAMERIC HUMAN CK2 HOLOENZYME REMARK 900 RELATED ID: 3RP0 RELATED DB: PDB DBREF 3RPS A 1 335 UNP P68400 CSK21_HUMAN 1 335 DBREF 3RPS B 1 335 UNP P68400 CSK21_HUMAN 1 335 SEQRES 1 A 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 335 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 A 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 335 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 A 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY SEQRES 1 B 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 B 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 B 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 B 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 B 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 B 335 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 B 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 B 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 B 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 B 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 B 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 B 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 B 335 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 B 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 B 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 B 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 B 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 B 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 B 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 B 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 B 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 B 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 B 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 B 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 B 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 B 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY HET 4B0 A 336 17 HET SO4 A 337 5 HET CL A 338 1 HET CL A 339 1 HET SO4 B 336 5 HET CL B 337 1 HET CL B 338 1 HETNAM 4B0 3-(4,5,6,7-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION FORMUL 3 4B0 C9 H7 BR4 N3 O FORMUL 4 SO4 2(O4 S 2-) FORMUL 5 CL 4(CL 1-) FORMUL 10 HOH *145(H2 O) HELIX 1 1 PRO A 20 ASP A 25 1 6 HELIX 2 2 TYR A 26 HIS A 29 5 4 HELIX 3 3 ASN A 35 ASP A 37 5 3 HELIX 4 4 LYS A 74 ARG A 89 1 16 HELIX 5 5 LEU A 124 LEU A 128 5 5 HELIX 6 6 THR A 129 MET A 150 1 22 HELIX 7 7 LYS A 158 HIS A 160 5 3 HELIX 8 8 SER A 194 LYS A 198 5 5 HELIX 9 9 GLY A 199 VAL A 204 1 6 HELIX 10 10 TYR A 211 ARG A 228 1 18 HELIX 11 11 ASP A 237 GLY A 250 1 14 HELIX 12 12 THR A 251 TYR A 261 1 11 HELIX 13 13 ASP A 266 GLY A 274 1 9 HELIX 14 14 ARG A 280 VAL A 285 5 6 HELIX 15 15 SER A 294 LEU A 305 1 12 HELIX 16 16 THR A 314 HIS A 321 1 8 HELIX 17 17 PHE A 324 GLN A 331 1 8 HELIX 18 18 ASP B 14 ARG B 19 1 6 HELIX 19 19 PRO B 20 ASP B 25 1 6 HELIX 20 20 ASN B 35 ASP B 37 5 3 HELIX 21 21 LYS B 74 ARG B 89 1 16 HELIX 22 22 THR B 129 MET B 150 1 22 HELIX 23 23 ASP B 175 ALA B 179 5 5 HELIX 24 24 SER B 194 LYS B 198 5 5 HELIX 25 25 GLY B 199 VAL B 204 1 6 HELIX 26 26 TYR B 211 ARG B 228 1 18 HELIX 27 27 ASP B 237 GLY B 250 1 14 HELIX 28 28 GLY B 250 TYR B 261 1 12 HELIX 29 29 ASP B 266 GLY B 274 1 9 HELIX 30 30 ARG B 280 VAL B 285 5 6 HELIX 31 31 GLU B 288 VAL B 293 5 6 HELIX 32 32 SER B 294 LEU B 305 1 12 HELIX 33 33 ASP B 308 ARG B 312 5 5 HELIX 34 34 THR B 314 HIS B 321 1 8 HELIX 35 35 PHE B 324 MET B 334 1 11 SHEET 1 A 5 TYR A 39 GLY A 46 0 SHEET 2 A 5 SER A 51 ASN A 58 -1 O GLU A 55 N ARG A 43 SHEET 3 A 5 LYS A 64 LEU A 70 -1 O VAL A 67 N PHE A 54 SHEET 4 A 5 PRO A 109 GLU A 114 -1 O LEU A 111 N LYS A 68 SHEET 5 A 5 LEU A 97 LYS A 102 -1 N ALA A 98 O VAL A 112 SHEET 1 B 2 ILE A 152 MET A 153 0 SHEET 2 B 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 C 2 VAL A 162 ASP A 165 0 SHEET 2 C 2 LYS A 170 LEU A 173 -1 O ARG A 172 N MET A 163 SHEET 1 D 5 TYR B 39 GLY B 46 0 SHEET 2 D 5 GLU B 52 ASN B 58 -1 O GLU B 55 N ARG B 43 SHEET 3 D 5 GLU B 63 ILE B 69 -1 O ILE B 69 N GLU B 52 SHEET 4 D 5 PRO B 109 GLU B 114 -1 O LEU B 111 N LYS B 68 SHEET 5 D 5 LEU B 97 LYS B 102 -1 N ALA B 98 O VAL B 112 SHEET 1 E 2 ILE B 152 MET B 153 0 SHEET 2 E 2 GLU B 180 PHE B 181 -1 O GLU B 180 N MET B 153 SHEET 1 F 2 VAL B 162 ASP B 165 0 SHEET 2 F 2 LYS B 170 LEU B 173 -1 O ARG B 172 N MET B 163 CISPEP 1 GLU A 230 PRO A 231 0 -13.01 CISPEP 2 GLU B 230 PRO B 231 0 -9.63 SITE 1 AC1 4 ARG A 47 LYS A 68 ASN A 117 ILE A 174 SITE 1 AC2 2 ARG A 21 LEU A 41 SITE 1 AC3 5 HIS A 148 THR A 314 ALA A 315 HOH A 348 SITE 2 AC3 5 HOH A 359 SITE 1 AC4 2 ARG A 155 ASN A 189 SITE 1 AC5 6 ARG B 21 GLN B 36 LEU B 41 ASP B 103 SITE 2 AC5 6 PRO B 104 HOH B 357 SITE 1 AC6 2 HIS B 148 ALA B 315 SITE 1 AC7 2 ARG B 155 ASN B 189 CRYST1 72.010 72.010 133.120 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013887 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013887 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007512 0.00000